Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 15,825Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Bausch Health, Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Bausch Health, Canada Inc.

arrow
World Drug Safety EU
Not Confirmed

Bausch Health, Canada Inc.

Country
arrow
World Drug Safety EU
Not Confirmed

HALOBETASOL PROPIONATE, TAZAROTENE

Brand Name : DUOBRII

Patent Number : 2817524

Filing Date : 2011-11-09

Strength per Unit : 0.01% w / w ; 0.045% w / w

Dosage Form : LOTION

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2031-11-09

Date Granted : 2019-11-05

blank

02

Bausch Health, Canada Inc.

arrow
World Drug Safety EU
Not Confirmed

Bausch Health, Canada Inc.

Country
arrow
World Drug Safety EU
Not Confirmed

HALOBETASOL PROPIONATE

Brand Name : BRYHALI

Patent Number : 2417646

Filing Date : 2001-07-24

Strength per Unit : 0.01%

Dosage Form : LOTION

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2021-07-24

Date Granted : 2010-05-04

blank

03

Bausch Health, Canada Inc.

arrow
World Drug Safety EU
Not Confirmed

Bausch Health, Canada Inc.

Country
arrow
World Drug Safety EU
Not Confirmed

HALOBETASOL PROPIONATE

Brand Name : BRYHALI

Patent Number : 2817524

Filing Date : 2011-11-09

Strength per Unit : 0.01%

Dosage Form : LOTION

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2031-11-09

Date Granted : 2019-11-05

blank